Rimidi Advanced Primary Care Model
Enhanced primary care delivery for chronic disease management
Company profile
Company profile
Rimidi is a healthcare technology company that specializes in chronic disease management and remote patient monitoring solutions. Now part of HRS (Health Recovery Solutions), Rimidi delivers a comprehensive platform that integrates directly into existing electronic health record (EHR) systems, enabling healthcare providers to manage complex chronic conditions more effectively. The company's approach combines configurable software with clinical monitoring services and connected medical devices to support various care delivery models including Remote Patient Monitoring (RPM), Chronic Care Management (CCM), Remote Therapeutic Monitoring (RTM), and Behavioral Health Integration. Rimidi's platform features enhanced decision support capabilities, patient prioritization tools, and seamless EHR integration to improve clinical workflows. The solution supports multiple chronic conditions through connected devices including blood glucose monitors, continuous glucose monitors, blood pressure cuffs, digital scales, pulse oximeters, and digital inhalers. Rimidi serves healthcare providers, health systems, and care delivery partners, offering comprehensive services including clinical monitoring, EHR integration support, patient onboarding, device management, and billing support. The platform is designed to address real-world healthcare challenges faced by clinicians, patients, and healthcare organizations by streamlining care coordination and enabling better clinical decision-making within existing clinical workflows.
Company description Rimidi official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Company milestones
Acquired by HRS (Health Recovery Solutions)
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Enhanced primary care delivery for chronic disease management
Integrated behavioral health support for chronic disease patients
Comprehensive CCM solution for better patient engagement and outcomes
CGM integration and management for diabetes care
Population health management for chronic disease programs
Configurable RPM programs with enhanced decision support, patient prioritization, and EHR integration
Remote therapeutic monitoring for chronic disease management
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Through improved chronic disease management and remote monitoring
Better workflows and clinical decisions within existing EHR
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Rimidi's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.